Literature DB >> 23242548

Lewis y antigen is expressed in oral squamous cell carcinoma cell lines and tissues, but disappears in the invasive regions leading to the enhanced malignant properties irrespective of sialyl-Lewis x.

Hiroshi Hotta1, Kazunori Hamamura, Kyoko Yamashita, Hidenobu Shibuya, Noriyo Tokuda, Noboru Hashimoto, Keiko Furukawa, Noriyuki Yamamoto, Hisashi Hattori, Shinya Toyokuni, Minoru Ueda, Koichi Furukawa.   

Abstract

Expression and implication of carbohydrate antigens in squamous cell carcinomas (SCCs) in oral cavity was examined. In the cell lines, type 2H and Lewis y antigens were markedly expressed. In the tissues from SCC patients and benign disorders, type 2H was highly expressed in hyperplasia (96.4 %), displasia (92.9 %) and SCC (100 %). Lewis y was, in turn, expressed mainly in cancer tissues (91.3 %), suggesting that Lewis y is a cancer-associated antigen. Normal oral mucosa showed no expression of these blood group antigens. Surprisingly, Lewis y antigen disappeared in the invasion sites where Ki-67 was definitely stained. Over-expression of Lewis y with manipulation of a fucosyltransferase cDNA resulted in suppression of cell growth and invasion, and knockdown of Lewis y also brought about increased cell growth and invasion. In either situations, no changes in the expression of sialyl-Lewis x could be found. Lowered tumor growth and invasion into surrounding tissues were also shown in Lewis y-positive SCC grafts in nu/nu mice. All these results together with alternative staining between Lewis y and Ki-67 in cancer tissues and FUT1 transfectants suggested that loss of Lewis y is a crucial event for the late stage of SCCs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23242548     DOI: 10.1007/s10719-012-9458-2

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  31 in total

1.  Free Anterolateral Thigh Flap for Reconstruction of Head and Neck Defects following Cancer Ablation.

Authors:  Isao Koshima
Journal:  Plast Reconstr Surg       Date:  2000-06       Impact factor: 4.730

Review 2.  ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution.

Authors:  H Clausen; S Hakomori
Journal:  Vox Sang       Date:  1989       Impact factor: 2.144

3.  Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells.

Authors:  Ying-Chih Liu; Hsin-Yung Yen; Chien-Yu Chen; Chein-Hung Chen; Ping-Fu Cheng; Yi-Hsiu Juan; Chung-Hsuan Chen; Kay-Hooi Khoo; Chong-Jen Yu; Pan-Chyr Yang; Tsui-Ling Hsu; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

Review 4.  Implication of N-acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism.

Authors:  N Taniguchi; E Miyoshi; J H Ko; Y Ikeda; Y Ihara
Journal:  Biochim Biophys Acta       Date:  1999-10-08

5.  Premalignant and malignant oral lesions are associated with changes in the glycosylation pattern of carbohydrates related to ABH blood group antigens.

Authors:  E Dabelsteen; H Clausen; P Holmstrup; J Reibel
Journal:  APMIS       Date:  1988-09       Impact factor: 3.205

6.  Histo-blood group A/B versus H status of human carcinoma cells as correlated with haptotactic cell motility: approach with A and B gene transfection.

Authors:  D Ichikawa; K Handa; D A Withers; S Hakomori
Journal:  Cancer Res       Date:  1997-08-01       Impact factor: 12.701

7.  Loss of expression of blood group antigen H is associated with cellular invasion and spread of oral squamous cell carcinomas.

Authors:  M Bryne; P S Thrane; E Dabelsteen
Journal:  Cancer       Date:  1991-02-01       Impact factor: 6.860

Review 8.  Blood group-related carbohydrate antigen expression in malignant and premalignant colonic neoplasms.

Authors:  S H Itzkowitz
Journal:  J Cell Biochem Suppl       Date:  1992

9.  Distribution of blood group antigens A, B, H, Lewisa, and Lewisb in human normal, fetal, and malignant colonic tissue.

Authors:  M Yuan; S H Itzkowitz; A Palekar; A M Shamsuddin; P C Phelps; B F Trump; Y S Kim
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

10.  Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I.

Authors:  Lili Gao; Limei Yan; Bei Lin; Jian Gao; Xiuyun Liang; Yanyan Wang; Juanjuan Liu; Shulan Zhang; Masao Iwamori
Journal:  J Exp Clin Cancer Res       Date:  2011-02-07
View more
  5 in total

1.  Identification of α1,2-fucosylated signaling and adhesion molecules in head and neck squamous cell carcinoma.

Authors:  Brittany Montesino; Agata Steenackers; Juan M Lozano; Geoffrey D Young; Nan Hu; Robert Sackstein; Kevin Brown Chandler
Journal:  Glycobiology       Date:  2022-04-21       Impact factor: 4.313

2.  β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.

Authors:  Kevin Brown Chandler; Khalid A Alamoud; Vanessa L Stahl; Bach-Cuc Nguyen; Vinay K Kartha; Manish V Bais; Kenichi Nomoto; Takashi Owa; Stefano Monti; Maria A Kukuruzinska; Catherine E Costello
Journal:  Mol Omics       Date:  2020-03-23

3.  Carcinoma-associated fucosylated antigens are markers of the epithelial state and can contribute to cell adhesion through CLEC17A (Prolectin).

Authors:  Adrien Breiman; María Dolores López Robles; Sophie de Carné Trécesson; Klara Echasserieau; Karine Bernardeau; Kurt Drickamer; Anne Imberty; Sophie Barillé-Nion; Frédéric Altare; Jacques Le Pendu
Journal:  Oncotarget       Date:  2016-03-22

Review 4.  The Diverse Contributions of Fucose Linkages in Cancer.

Authors:  Tyler S Keeley; Shengyu Yang; Eric Lau
Journal:  Cancers (Basel)       Date:  2019-08-24       Impact factor: 6.639

5.  Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells.

Authors:  Tomoaki Furuta; Tatsuya Oda; Kayo Kiyoi; Ozawa Yusuke; Sota Kimura; Ko Kurimori; Yoshihiro Miyazaki; Yang Yu; Kinji Furuya; Yoshimasa Akashi; Osamu Shimomura; Hiroaki Tateno
Journal:  Cancer Sci       Date:  2021-06-29       Impact factor: 6.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.